Literature DB >> 33343696

A case of paramyotonia congenita in pregnancy.

E K Brooks1, D Schweitzer2, H L Robinson1,3.   

Abstract

Paramyotonia congenita is a rare autosomal dominant non-dystrophic myopathy caused by mutations in the SNC4A gene, which encodes for the voltage-gated sodium channel in skeletal muscle. Symptom onset is typically during early childhood and is characterised by myotonia followed by flaccid paralysis or weakness, usually exacerbated by repeated muscle contractions or cold temperatures. Pregnancy has been reported to increase symptoms of myotonia; however, there is limited information in the literature regarding the possible effects of paramyotonia congenita on pregnancy and labour. We present a successful case of a 20-year-old primigravida with confirmed paramyotonia congenita and review the literature regarding paramyotonia congenita during pregnancy.
© The Author(s) 2019.

Entities:  

Keywords:  Paramyotonia congenita; high-risk pregnancy; vaginal delivery

Year:  2019        PMID: 33343696      PMCID: PMC7726174          DOI: 10.1177/1753495X18816171

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  19 in total

1.  Caesarean section in a patient with paramyotonia congenita.

Authors:  R F Grace; V J Roach
Journal:  Anaesth Intensive Care       Date:  1999-10       Impact factor: 1.669

2.  Paramyotonia congenita in 22 members of an Arab (Omani) kindred.

Authors:  Roshan Koul; Amna Alfutaisi; Manjusha Hira
Journal:  J Child Neurol       Date:  2009-01-23       Impact factor: 1.987

Review 3.  Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  J P Monk; R N Brogden
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

4.  Cold-induced abortion in paramyotonia congenita.

Authors:  D Chitayat; M Etchell; R D Wilson
Journal:  Am J Obstet Gynecol       Date:  1988-02       Impact factor: 8.661

5.  Stridor as a neonatal presentation of skeletal muscle sodium channelopathy.

Authors:  Emma Matthews; Adnan Y Manzur; Richa Sud; Francesco Muntoni; Michael G Hanna
Journal:  Arch Neurol       Date:  2011-01

6.  Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: a new treatable disorder.

Authors:  L Lion-Francois; C Mignot; S Vicart; V Manel; D Sternberg; P Landrieu; G Lesca; E Broussolle; T Billette de Villemeur; S Napuri; V des Portes; B Fontaine
Journal:  Neurology       Date:  2010-08-17       Impact factor: 9.910

7.  A SCN4A mutation causing paramyotonia congenita.

Authors:  Carmen Palma; Carmen Prior; Clara Gómez-González; Carlos Rodríguez-Antolin; Paloma Martínez-Montero; Lucía Pérez de Ayala; Samuel I Pascual; Jesús Molano Mateos
Journal:  Neuromuscul Disord       Date:  2017-09-25       Impact factor: 4.296

8.  Skeletal muscle na channel disorders.

Authors:  Dina Simkin; Saïd Bendahhou
Journal:  Front Pharmacol       Date:  2011-10-14       Impact factor: 5.810

9.  Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.

Authors:  Jaya R Trivedi; Brian Bundy; Jeffrey Statland; Mohammad Salajegheh; Dipa Raja Rayan; Shannon L Venance; Yunxia Wang; Doreen Fialho; Emma Matthews; James Cleland; Nina Gorham; Laura Herbelin; Stephen Cannon; Anthony Amato; Robert C Griggs; Michael G Hanna; Richard J Barohn
Journal:  Brain       Date:  2013-06-13       Impact factor: 13.501

Review 10.  Myotonic disorders: A review article.

Authors:  Chris Hahn; Mohammad Kian Salajegheh
Journal:  Iran J Neurol       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.